Plerixafor USP 20 mg/ml Injection Solution
Real Overseas · Verified Seller · Jamnagar, Gujarat
Plerixafor USP 20 mg/ml Injection Solution: manufactured in Jamnagar, Gujarat by Real Overseas. Verified seller on Tradoi. At ₹10,500/piece, MOQ 2 pieces.
Price and Order
| Price | ₹10,500 per piece |
|---|---|
| Minimum Order Quantity | 2 piece |
- Tracked Order
- Private Contact
- Tradoi-Verified Seller
Specifications
From the Seller's Listing
| Category | Healthcare & Medical › Pharmaceutical Products › Injectables & Infusions |
|---|---|
| Unit | piece |
| Api Name | Plerixafor USP |
| Excipients | Sodium Chloride in Water for injection adjusted to a pH of 6.0 to 7.5 with Hydrochloric Acid and with Sodium Hydroxide, if required |
| Dosage Form | Solution |
| Concentration | 20 mg/ml |
| Container Type | Vial |
| Action | Rapid Mobilization of Hematopoietic Stem Cells |
| Product Name | Mozifor Plerixafor Injection 24mg |
| Optimized For | Non-Hodgkin's Lymphoma and Myelom |
| Preservatives | no preservatives |
| Target Receptor | CXCR4 Receptor |
| Storage Condition | 59-86°F |
| Mechanism Of Action | Antagonist |
Trade and Delivery
| Seller Location | Jamnagar, Gujarat |
|---|---|
| Ships To | Pan-India |
Description
Plerixafor USP 20 mg/ml solution for injection, supplied in vials, is specifically formulated as a CXCR4 Receptor Antagonist for rapid mobilization of hematopoietic stem cells, optimized for therapeutic use in Non-Hodgkin's Lymphoma and Myeloma treatment protocols.
Key Features
- Plerixafor USP active pharmaceutical ingredient — meets United States Pharmacopeia standards for purity and potency.
- 20 mg/ml concentration — provides precise dosing for therapeutic applications requiring specific Plerixafor levels.
- Solution dosage form — ensures immediate bioavailability and suitability for injection, facilitating rapid action.
- Supplied in vials — designed for sterile, single-use administration, minimizing contamination risks in clinical settings.
- CXCR4 Receptor Antagonist mechanism of action — specifically targets the CXCR4 receptor for effective stem cell mobilization.
- Optimized for Non-Hodgkin's Lymphoma and Myeloma — tailored for critical use in specific hematological malignancy treatments.
- Rapid mobilization of hematopoietic stem cells — facilitates efficient collection for autologous transplantation procedures.
- Preservative-free formulation — reduces potential for allergic reactions or sensitivities in patients.
- Storage condition 15-30°C (59-86°F) — ensures product stability and efficacy under standard pharmaceutical storage protocols.
Applications
- Oncology Departments: For pre-transplant conditioning in patients undergoing autologous stem cell transplantation.
- Stem Cell Transplant Centers: Essential for mobilizing hematopoietic stem cells in Non-Hodgkin's Lymphoma and Myeloma.
- Hospital Pharmacies: Stocking critical medications for hematology and oncology treatment protocols.
- Research Institutions: Utilized in clinical trials and studies focused on stem cell biology and cancer therapy.
Detailed Description
Plerixafor USP 20 mg/ml solution for injection is precisely manufactured as a CXCR4 Receptor Antagonist, designed to facilitate the rapid mobilization of hematopoietic stem cells. This sterile solution is supplied in vials, ensuring controlled dosage and administration. Each formulation is carefully prepared without preservatives, containing Sodium Chloride in Water for injection, with pH adjusted to 6.0 to 7.5 using Hydrochloric Acid and Sodium Hydroxide as required, maintaining stability and efficacy. This specialized pharmaceutical product is critical for oncology departments, stem cell transplant centers, and research institutions focused on advanced hematological treatments. It serves as a vital component in pre-transplant conditioning regimens, enabling efficient stem cell collection for autologous transplantation in patients with Non-Hodgkin's Lymphoma and Myeloma. Procurement managers in large hospital networks and specialized clinics will find this product essential for their therapeutic inventories. Produced under stringent quality controls, this Plerixafor injection is stored at conditions between 15-30°C (59-86°F) to maintain its pharmaceutical integrity and potency throughout its shelf life. The manufacturing process adheres to industry best practices, ensuring a consistent and reliable product for critical medical applications.
Sold By
Real Overseas
Verified Seller · Jamnagar, Gujarat
Manufacturer of high-strength industrial equipment, musical instrument components, and winter blankets for buyers across India.
Checked by Tradoi
- Business certificate checked
Said by the Seller
- Online presence
- Manufacturer, Wholesaler
- Reach: Pan India
Seen on Tradoi
- On Tradoi since Apr 2026
61 Items in Catalog
More from Real Overseas
Other Products from This Seller's Catalog
Similar Products from Other Sellers
Common Buyer Questions
Based on the seller's listing. Don't see your question? Ask the seller in chat.
What is the minimum order quantity for Plerixafor USP 20 mg/ml Injection Solution?
The minimum order quantity (MOQ) for Plerixafor USP 20 mg/ml Injection Solution is 2 piece.
Who manufactures Plerixafor USP 20 mg/ml Injection Solution?
Plerixafor USP 20 mg/ml Injection Solution is manufactured by Real Overseas, a Tradoi-verified manufacturer based in Jamnagar, Gujarat.
What is the price of Plerixafor USP 20 mg/ml Injection Solution?
Plerixafor USP 20 mg/ml Injection Solution is priced at ₹10,500 per piece by Real Overseas. Minimum order quantity is 2 piece. Pricing may vary with order volume — contact the supplier on Tradoi to confirm bulk rates.
How can I buy Plerixafor USP 20 mg/ml Injection Solution in bulk?
Plerixafor USP 20 mg/ml Injection Solution is available for bulk purchase directly from Real Overseas in Jamnagar on Tradoi. Submit an RFQ or contact the supplier to discuss volumes above 2 piece and negotiate pricing.